Wilex AG – Product Pipeline Review – 2012
May, 2012 · 80 pages
|
US$ 500.00 |
Vertex Pharmaceuticals Incorporated – Product Pipeline Review – 2012
May, 2012 · 139 pages
|
US$ 500.00 |
Taiho Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012
May, 2012 · 109 pages
|
US$ 500.00 |
Supernus Pharmaceuticals, Inc. – Product Pipeline Review – 2012
May, 2012 · 40 pages
|
US$ 500.00 |
Spectrum Pharmaceuticals, Inc. – Product Pipeline Review – 2012
May, 2012 · 141 pages
|
US$ 500.00 |
Sigma-Tau S.p.A. – Product Pipeline Review – 2012
May, 2012 · 99 pages
|
US$ 500.00 |
Santen Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012
May, 2012 · 92 pages
|
US$ 500.00 |
Recordati S.p.A. – Product Pipeline Review – 2012
May, 2012 · 113 pages
|
US$ 500.00 |
Ono Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012
May, 2012 · 115 pages
|
US$ 500.00 |
NPS Pharmaceuticals, Inc. – Product Pipeline Review – 2012
May, 2012 · 72 pages
|
US$ 500.00 |
Newron Pharmaceuticals S.p.A. – Product Pipeline Review – 2012
May, 2012 · 64 pages
|
US$ 500.00 |
Neuren Pharmaceuticals Limited – Product Pipeline Review – 2012
May, 2012 · 72 pages
|
US$ 500.00 |
Mitsubishi Tanabe Pharma Corporation – Product Pipeline Review – 2012
May, 2012 · 131 pages
|
US$ 500.00 |
Lupin Limited – Product Pipeline Review – 2012
May, 2012 · 79 pages
|
US$ 500.00 |
Lexicon Pharmaceuticals, Inc. – Product Pipeline Review – 2012
May, 2012 · 87 pages
|
US$ 500.00 |
LEO Pharma A/S – Product Pipeline Review – 2012
May, 2012 · 100 pages
|
US$ 500.00 |
Kuros Biosurgery AG – Product Pipeline Review – 2012
May, 2012 · 44 pages
|
US$ 500.00 |
Keryx Biopharmaceuticals, Inc. – Product Pipeline Review – 2012
May, 2012 · 85 pages
|
US$ 500.00 |
Hospira, Inc. – Product Pipeline Review – 2012
May, 2012 · 111 pages
|
US$ 500.00 |
Gilead Sciences, Inc. – Product Pipeline Review – 2012
May, 2012 · 261 pages
|
US$ 500.00 |
Galderma S.A. – Product Pipeline Review – 2012
May, 2012 · 69 pages
|
US$ 500.00 |
Ferring Pharmaceuticals, Inc. – Product Pipeline Review – 2012
May, 2012 · 38 pages
|
US$ 500.00 |
Evotec Aktiengesellschaft – Product Pipeline Review – 2012
May, 2012 · 195 pages
|
US$ 500.00 |
Emergent BioSolutions Inc. – Product Pipeline Review – 2012
May, 2012 · 126 pages
|
US$ 500.00 |
Eli Lilly and Company – Product Pipeline Review – 2012
May, 2012 · 621 pages
|
US$ 500.00 |
Dr. Reddy's Laboratories Limited – Product Pipeline Review – 2012
May, 2012 · 134 pages
|
US$ 500.00 |
Dainippon Sumitomo Pharma Co., Ltd. – Product Pipeline Review – 2012
May, 2012 · 152 pages
|
US$ 500.00 |
Cubist Pharmaceuticals, Inc. – Product Pipeline Review – 2012
May, 2012 · 111 pages
|
US$ 500.00 |
CSL Limited – Product Pipeline Review – 2012
May, 2012 · 104 pages
|
US$ 500.00 |
Chelsea Therapeutics International Ltd. – Product Pipeline Review – 2012
May, 2012 · 89 pages
|
US$ 500.00 |
CEL-SCI Corporation – Product Pipeline Review – 2012
May, 2012 · 82 pages
|
US$ 500.00 |
Celldex Therapeutics, Inc. – Product Pipeline Review – 2012
May, 2012 · 82 pages
|
US$ 500.00 |
BTG plc – Product Pipeline Review – 2012
May, 2012 · 120 pages
|
US$ 500.00 |
Boehringer Ingelheim GmbH – Product Pipeline Review – 2012
May, 2012 · 285 pages
|
US$ 500.00 |
Bionovo, Inc. – Product Pipeline Review – 2012
May, 2012 · 68 pages
|
US$ 500.00 |
BioMarin Pharmaceutical Inc. – Product Pipeline Review – 2012
May, 2012 · 96 pages
|
US$ 500.00 |
Ark Therapeutics Group plc – Product Pipeline Review – 2012
May, 2012 · 66 pages
|
US$ 500.00 |
Anavex Life Sciences Corp. - Product Pipeline Review - 2012
May, 2012 · 54 pages
|
US$ 500.00 |
Agenus, Inc. – Product Pipeline Review – 2012
May, 2012 · 73 pages
|
US$ 500.00 |
ADVENTRX Pharmaceuticals, Inc. – Product Pipeline Review – 2012
May, 2012 · 90 pages
|
US$ 500.00 |
ACADIA Pharmaceuticals Inc. – Product Pipeline Review – 2012
May, 2012 · 78 pages
|
US$ 500.00 |
Oral Cancer – Pipeline Review, H1 2012
Apr, 2012 · 70 pages
|
US$ 500.00 |
Neuroendocrine Tumors – Pipeline Review, H1 2012
Apr, 2012 · 68 pages
|
US$ 500.00 |
Neuro Endocrine (Carcinoid) Carcinoma – Pipeline Review, H1 2012
Apr, 2012 · 104 pages
|
US$ 500.00 |
Left Ventricular Hypertrophy – Pipeline Review, H1 2012
Apr, 2012 · 30 pages
|
US$ 500.00 |
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) – Pipeline Review, H1 2012
Apr, 2012 · 101 pages
|
US$ 500.00 |
Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H1 2012
Apr, 2012 · 205 pages
|
US$ 500.00 |
Uterine Leiomyoma (Uterine Fibroids) – Pipeline Review, H1 2012
Mar, 2012 · 26 pages
|
US$ 500.00 |
United Arab Emirates Surgical Equipment Investment Opportunities, Analysis and Forecasts to 2018
Mar, 2012 · 49 pages
|
US$ 2,500.00 |
United Arab Emirates Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2017
Mar, 2012 · 115 pages
|
US$ 2,500.00 |
